ClinicalTrials.gg
Enrolling by invitationNCT06338319BOOSTUpdated May 23, 2025

Book Sharing for Toddlers With Clefts

An interventional study of Book-Sharing for Toddlers with Clefts (BOOST) in Cleft Palate and Cleft Lip and Palate, sponsored by Seattle Children's Hospital. Enrolling by invitation at 1 site in United States. Open to participants aged 20 Months to 32 Months. Per ClinicalTrials.gov, last updated 2025-05-23.

Sponsored by Seattle Children's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
320
Allocation
Randomized
Ages
20 Months to 32 Months
Sex
All
01

Study summary

Children with clefts exhibit difficulty with language and literacy compared to children without clefts. However, little is known about interventions to address these difficulties in the cleft population. This study will test the efficacy of a parent-focused dialogic book-sharing intervention for toddlers with isolated cleft palate. The study will use a randomized controlled trial (RCT) design and Intention to Treat (ITT) analyses. Child outcomes include expressive and receptive language. Parent outcomes of interest include the frequency and quality of shared reading interactions. To assess mechanisms of action, the study will test whether changes in child outcomes are mediated by changes in parents' behavior. Analyses will also explore heterogeneity in outcomes to determine whether the intervention is more effective in certain clinical or demographic sub-groups.

02

Conditions studied

  • Cleft Palate
  • Cleft Lip and Palate
03

In context

Cleft Palate

123 studies on the registry are indexed under Cleft Palate; 35 are open to participants now.

This study's planned enrollment of 320 is above the median of 44 across 77 interventional studies indexed under Cleft Palate.

Browse Cleft Palate studies →

Lead sponsor

Seattle Children's Hospital is the lead sponsor of 215 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Months to 32 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A child's parent or primary caregiver provides a signed and dated form and permission for their child to participate.
  • A child's parent is willing to comply with all study procedures and be available for the duration of the study.
  • Child is between the ages of 20 to 32 months at the time of enrollment.
  • Child has been diagnosed with isolated cleft palate, with or without cleft lip.
  • Child has received palate repair surgery.
  • The family's preferred language is English or Spanish.
  • The family has access to a smartphone or similar device (e.g., tablets) capable of recording and sending videos.

Exclusion criteria

Exclusion Criteria:

  • Diagnosed genetic condition associated with developmental delay (e.g., 22q11 deletion).
  • The child has a diagnosis of autism spectrum disorder
  • The child has a tracheostomy tube
  • Child delivered \< 32 weeks' gestation.
  • Child in state custody or foster care.
  • Child with significant sensory impairment (blindness, sensorineural hearing loss).
  • The caregiver speaks a language other than English or Spanish
  • The caregiver does not own a smartphone or similar device capable of recording/sending video
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
320 participants (estimated)

Study arms

  • Experimental
    BOOST Program

    Parents in the BOOST Program group will receive books to read with their children and send smartphone video recordings of their reading interactions. To provide support, parents will participate in 3 remote, parent-focused book-sharing intervention sessions

    Behavioral: Book-Sharing for Toddlers with Clefts (BOOST)

  • No intervention
    Standard of Care Comparison Group

    Parents in the Standard of Care Comparison Group will receive books to read with their children and send smartphone video recordings of their reading interactions. Parents in the comparison group will not participate in BOOST intervention sessions.

Interventions

  • BehavioralBook-Sharing for Toddlers with Clefts (BOOST)

    BOOST is a dialogic book-sharing intervention. Topics covered include strategies to increase the frequency of shared reading, child engagement and involvement in reading, and strategies to promote language development. Handouts will be shared during the sessions (using the Zoom share screen feature) and sent to families to summarize the content. Parents will record and securely upload shared reading videos during the intervention period. The research team will send prompts for these video uploads after each intervention session. Interventionists will review these videos between sessions to identify parent strengths, application of target skills, and opportunities for improvement.

06

What researchers measure

Primary outcomes

  1. Expressive One Word Picture Vocabulary Test-Fourth Edition

    Standardized, clinician-administered measure of expressive language. Possible raw scores range from 0 to 190, with higher scores indicating better expressive language

    Time frame: End of study (At least 8 weeks after the end of the intervention period)

  2. Receptive One Word Picture Vocabulary Test-Fourth Edition

    Standardized, clinician-administered measure of receptive language. Raw scores range from 0 to 190, with higher scores indicating better receptive language.

    Time frame: End of study (At least 8 weeks after the end of the intervention period)

  3. Child Language Sample

    Observational measure to assess child expressive language. We will obtain a count of the number of clear and intelligible utterances, the number of unique words used, and mean length of utterance. Higher scores indicate better child language skills.

    Time frame: End of study (At least 8 weeks after the end of the intervention period)

  4. MacArthur-Bates Communicative Development Inventory - Computer Adaptive Test

    Parent report measure of children's expressive language. Raw scores range from 0 to 50, with higher scores indicating better expressive language.

    Time frame: Baseline and at end of study (at least 8 weeks after the end of the intervention period)

Secondary outcomes

  1. Child Speech Sample - Percent Consonants Correct - Revised, Total Number of Unique Consonants

    Parent-administered measure to assess children's speech sound inventory and production accuracy. Children will be asked to name approximately 27 pictures. Responses will be recorded and phonetically transcribed to obtain a count of consonant sounds attempted and consonant sounds correct in the beginning, middle, and final positions for the pictured words. We will use these counts to obtain percent consonants correct - revised (#consonants correct/#consonants attempted). Higher scores indicate better speech sound accuracy. We will also count the total number of unique consonants produced, with higher scores indicating larger phonetic inventory.

    Time frame: Baseline and at end of study (at least 8 weeks after the end of the intervention period)

Other outcomes

  1. Frequency of Shared Reading

    Parent report measure of shared reading, reported as the number of books read with their child in the last 24-hours. Higher scores indicate more frequent shared reading.

    Time frame: Throughout the intervention period of approximately 8 weeks and again at end of study (at least 8 weeks after the end of the intervention period)

  2. Quality of Shared Reading

    Observational measure of parent-child reading interactions, including a count of the dialogic book-sharing strategies used during the observation. Higher scores indicate higher quality shared reading interaction.

    Time frame: Throughout the intervention period of approximately 8 weeks and again at end of study (at least 8 weeks after the end of the intervention period)

  3. Child Language During Reading

    Observation of child language during reading interactions, including a count of the number of clear and intelligible utterances the child uses, the number of unique words, and the mean length of utterance. Higher scores will indicate better observed child language skills.

    Time frame: Throughout the intervention period of approximately 8 weeks and again at end of study (at least 8 weeks after the end of the intervention period)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06338319
Responsible party
Sponsor
First posted
Mar 29, 2024
Start date
May 1, 2024
Primary completion
Jun 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
May 23, 2025

Study contacts

Brent Collett, PhD
principal investigator · Seattle Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion